Clinical Trial Update: Gemcitabine in Combination With Pemetrexed Long Term Infusion in the Treatment of Pretreated Metastatic Colorectal Cancer Patients [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating gemcitabine in combination with pemetrexed long-term infusion for pretreated metastatic colorectal cancer; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Alimta (pemetrexed)
• Gemzar (gemcitabine)

Snippet

Sponsor: Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS | Conditions: Colorectal Cancer Metastatic | Phase 2 | Status: COMPLETED